Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

It will be Cytodyn's Leronlimab and not any RdPp drug like Remde. Leronlimab is trending to be a potential SoC for COVID-19, and it should once the data comes out.

Remde is ineffective when it came addressing severe and critically ill patients; and due to the specificity of Bril's MOA, Bril could be as good or better than Leronlimab. I am excited to see our Phase II trials get going.

Timing is of the essence so I hope everything is lined up and ahead of schedule. We are a bit slow on the execution part, but now that we have $36M of cash, I hope we get moving FAST!!